Mariner’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Hold
91,666
﹤0.01% 2923
2026
Q1
$91.7K Sell
91,666
-2,322
-2% -$2.23K ﹤0.01% 3345
2025
Q4
$32K Buy
93,988
+100
+0.1% +$34 ﹤0.01% 3455
2025
Q3
$32.4K Hold
93,888
﹤0.01% 3483
2025
Q2
$20.7K Hold
93,888
﹤0.01% 3419
2025
Q1
$22.3K Hold
93,888
﹤0.01% 3369
2024
Q4
$19.7K Hold
93,888
﹤0.01% 3349
2024
Q3
$17.8K Hold
93,888
﹤0.01% 3254
2024
Q2
$19K Hold
93,888
﹤0.01% 3114
2024
Q1
$23.5K Hold
93,888
﹤0.01% 3086
2023
Q4
$18.1K Hold
93,888
﹤0.01% 3005
2023
Q3
$23.7K Hold
93,888
﹤0.01% 2835
2023
Q2
$37.1K Hold
93,888
﹤0.01% 2742
2023
Q1
$26K Hold
93,888
﹤0.01% 2707
2022
Q4
$23K Hold
93,888
﹤0.01% 2677
2022
Q3
$42K Buy
+93,888
New +$55.4K ﹤0.01% 2328

Other funds holding DRTSW

Mariner's DRTSW Position: Q2 2026 in Review

Mariner held its Alpha Tau Medical Warrant (DRTSW) position steady in Q2 2026 at 91,666 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #2923.

Mariner first reported a position in DRTSW in Q3 2022 and has held it in 16 quarters since. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • Mariner held 91,666 shares of Alpha Tau Medical Warrant worth $270K as of Q2 2026.
  • Mariner left its Alpha Tau Medical Warrant share count unchanged in Q2 2026.
  • Alpha Tau Medical Warrant made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2923 holding.
  • Mariner first reported a position in Alpha Tau Medical Warrant in Q3 2022 and has held it in 16 quarters since.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.